Utilization of P2Y12 Inhibitors in Older Adults With ST-Elevation Myocardial Infarction and Frailty-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Utilization of P2Y12 Inhibitors in Older Adults With ST-Elevation Myocardial Infarction and Frailty

Published:2023-11 Issue: Volume:207 Page:245-252
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Ko Darae,Pande Ashvin,Lin Kueiyu Joshua,Cervone Alexander,Bessette Lily G.,Lee Su Been,Cheng Susan,Glynn Robert J.,Kim Dae Hyun

Funder

National Institutes of Health

National Institute on Aging

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Frailty among older adults with acute myocardial infarction and outcomes from percutaneous coronary interventions;Damluji;J Am Heart Assoc,2019

2. Influence of frailty and health status on outcomes in patients with coronary disease undergoing percutaneous revascularization;Singh;Circ Cardiovasc Qual Outcomes,2011

3. Frailty and clinical outcomes of direct oral anticoagulants versus warfarin in older adults with atrial fibrillation: A cohort study;Kim;Ann Intern Med,2021

4. TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes;Wiviott;N Engl J Med,2007

5. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unleashing frailty from laboratory into real world: A critical step toward frailty‐guided clinical care of older adults;Journal of the American Geriatrics Society;2024-08-21

2. Frailty and Clinical Outcomes of Ticagrelor Versus Clopidogrel in Older Adults With Acute Myocardial Infarction;Journal of the American Heart Association;2024-08-06

3. Assessing the Benefits and Harms of Pharmacotherapy in Older Adults with Frailty: Insights from Pharmacoepidemiologic Studies of Routine Health Care Data;Drugs & Aging;2024-07

4. Frailty as an Effect Modifier in Randomized Controlled Trials: A Systematic Review;Journal of General Internal Medicine;2024-04-09

5. Frailty and P2Y12 Inhibitors: Does The Best Approach Need to Be Black or White?;The American Journal of Cardiology;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3